PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 14712293-3 2004 Here, we describe the establishment and phenotypic characterization of U937 cells in which P210 BCR/ABL can be conditionally expressed using tetracycline. Tetracycline 141-153 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 96-103 16954505-8 2007 Tetracycline-inducible expression of KLF4 in B-cell progenitors of transgenic mice blocks transformation by BCR-ABL and depletes leukemic pre-B cells in vivo. Tetracycline 0-12 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 108-115 22169319-2 2011 To date, a number of BCR/ABL transgenic animal models have been established using different promoter or tetracycline-controlling system. Tetracycline 104-116 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 21-28 12821944-4 2003 The enforced expression of BCR-ABL in an ES cell line, engineered to express a tetracycline-inducible dominant-negative form of a STAT3, triggered ES cell differentiation with an increased generation of hematopoietic cells expressing erythroid and megakaryocytic phenotypes. Tetracycline 79-91 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 27-34 11526595-3 2001 A tetracycline-regulated promoter was developed to drive Bcr-Abl expression in differentiating embryonal stem cells. Tetracycline 2-14 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 57-64 12138893-4 2002 We have developed an in vitro system that mirrors the chronic phase of CML with a combination of in vitro embryonic stem cell differentiation and tetracycline-inducible Bcr-Abl expression. Tetracycline 146-158 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 169-176 11010972-5 2000 First, induction of BCR/ABL by a tetracycline-regulated promoter is associated with a reversible down-regulation of p27(Kip1). Tetracycline 33-45 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 20-27 10677527-6 2000 We utilized tetracycline-regulated expression of Bcr-Abl from a promoter engineered for robust expression in primitive stem cells through multilineage blood cell development in combination with the in vitro differentiation of embryonal stem cells into hematopoietic elements. Tetracycline 12-24 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 49-56 28024479-12 2016 Tetracycline induced its expression for 48 h and 72 h. pTER117, pTER363 decreased the mRNA level of BCR/ABL 90%, 82% and 91.5%, 84%, respectively, P210 protein were almost measured in K562 cells. Tetracycline 0-12 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 100-107